Search Results

There are 9270 results for: content related to: Atorvastatin, 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Reduces Bone Resorption in the Elderly

  1. You have free access to this content
    ASBMR 26th Annual Meeting SU001–SU586

    Journal of Bone and Mineral Research

    Volume 19, Issue S1, 2004, Pages: S204–S343,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650191305

  2. You have free access to this content
    ASBMR 27th Annual Meeting M001–M525

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S313–S437,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201306

  3. Intramuscular extended-release naltrexone: current evidence

    Annals of the New York Academy of Sciences

    Volume 1216, Issue 1, January 2011, Pages: 144–166, David R. Gastfriend

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1749-6632.2010.05900.x

    Corrected by:

    Corrigendum for Ann. N. Y. Acad. Sci. 1216: 144–166

    Vol. 1224, Issue 1, 207, Version of Record online: 12 APR 2011

  4. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals

    Alcoholism: Clinical and Experimental Research

    Volume 39, Issue 9, September 2015, Pages: 1832–1841, Dennis D. Rasmussen, Carrie L. Kincaid and Janice C. Froehlich

    Version of Record online : 11 AUG 2015, DOI: 10.1111/acer.12828

  5. Development of Naltrexone Supersensitivity During Food-Maintained Responding Enhances Naltrexone's Ability to Reduce Ethanol-Maintained Responding

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 1, January 2007, Pages: 39–47, Keith L. Williams

    Version of Record online : 15 DEC 2006, DOI: 10.1111/j.1530-0277.2006.00272.x

  6. Transdermal delivery of naltrexone and its active metabolite 6-β-naltrexol in human skin in vitro and guinea pigs in vivo

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 9, September 2005, Pages: 1965–1975, Kalpana S. Paudel, Buchi N. Nalluri, Dana C. Hammell, Satyanarayana Valiveti, Paul Kiptoo, Mohamed O. Hamad, Peter A. Crooks and Audra L. Stinchcomb

    Version of Record online : 28 JUL 2005, DOI: 10.1002/jps.20398

  7. Specific and Nonspecific Effects of Naltrexone on Goal-Directed and Habitual Models of Alcohol Seeking and Drinking

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 7, July 2013, Pages: 1100–1110, Rachel A. Hay, Joshua H. Jennings, Dawnya L. Zitzman, Clyde W. Hodge and Donita L. Robinson

    Version of Record online : 7 FEB 2013, DOI: 10.1111/acer.12081

  8. You have free access to this content
    ASBMR 27th Annual Meeting SU001–SU527

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S190–S313,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201305

  9. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2777–2786, Mikolaj Milewski, Raghotham R. Pinninti and Audra L. Stinchcomb

    Version of Record online : 24 MAY 2012, DOI: 10.1002/jps.23189

  10. Alcohol Consumption Is Enhanced After Naltrexone Treatment

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 2, February 2007, Pages: 260–264, Jorge Juárez and Barrios De Tomasi Eliana

    Version of Record online : 18 JAN 2007, DOI: 10.1111/j.1530-0277.2006.00313.x

  11. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

    Addiction

    Volume 112, Issue 6, June 2017, Pages: 1036–1044, Philip T. Korthuis, Paula J. Lum, Pamela Vergara-Rodriguez, Keith Ahamad, Evan Wood, Lynn E. Kunkel, Neal L. Oden, Robert Lindblad, James L. Sorensen, Virgilio Arenas, Doan Ha, Raul N. Mandler, Dennis McCarty and for the CTN-0055 CHOICES Investigators

    Version of Record online : 8 FEB 2017, DOI: 10.1111/add.13753

  12. You have free access to this content
    Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

    Cancer

    Volume 113, Issue 1, 1 July 2008, Pages: 193–201, Allan Lipton, Richard Cook, Fred Saad, Pierre Major, Patrick Garnero, Evangelos Terpos, Janet E. Brown and Robert E. Coleman

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23529

  13. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat

    Addiction Biology

    Volume 16, Issue 1, January 2011, Pages: 20–29, Jenny Häggkvist, Carl Björkholm, Pia Steensland, Sara Lindholm, Johan Franck and Björn Schilström

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1369-1600.2009.00199.x

  14. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial

    Clinical Pharmacology & Therapeutics

    Volume 100, Issue 4, October 2016, Pages: 344–352, ME Mooney, JM Schmitz, S Allen, J Grabowski, P Pentel, A Oliver and DK Hatsukami

    Version of Record online : 20 JUN 2016, DOI: 10.1002/cpt.402

  15. Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking Alcoholics

    Alcoholism: Clinical and Experimental Research

    Volume 32, Issue 3, March 2008, Pages: 498–504, Michael R. Lucey, Bernard L. Silverman, Ari Illeperuma and Charles P. O’Brien

    Version of Record online : 30 JAN 2008, DOI: 10.1111/j.1530-0277.2007.00593.x

  16. You have free access to this content
    Atorvastatin for lowering lipids

    Intervention Review

    The Cochrane Library

    Stephen P Adams, Michael Tsang and James M Wright

    Published Online : 11 MAR 2015, DOI: 10.1002/14651858.CD008226.pub3

  17. Straight-chain naltrexone ester prodrugs: Diffusion and concurrent esterase biotransformation in human skin

    Journal of Pharmaceutical Sciences

    Volume 91, Issue 12, December 2002, Pages: 2571–2578, Audra L. Stinchcomb, Peter W. Swaan, Opinya Ekabo, Kathleen K. Harris, Jennifer Browe, Dana C. Hammell, Todd A. Cooperman and Michael Pearsall

    Version of Record online : 24 SEP 2002, DOI: 10.1002/jps.10239

  18. You have free access to this content
    ASBMR 25th Annual Meeting SA001–SA483

    Journal of Bone and Mineral Research

    Volume 18, Issue S1, 2003, Pages: S100–S175,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650181304

  19. You have free access to this content
    Biological Variability of Serum and Urinary N-Telopeptides of Type I Collagen in Postmenopausal Women

    Journal of Bone and Mineral Research

    Volume 15, Issue 3, March 2000, Pages: 594–598, R. Eastell, N. Mallinak, S. Weiss, M. Ettinger, M. Pettinger, D. Cain, K. Flessland and C. Chesnut III

    Version of Record online : 18 FEB 2010, DOI: 10.1359/jbmr.2000.15.3.594

  20. You have full text access to this OnlineOpen article
    A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders

    Annals of the New York Academy of Sciences

    Volume 1327, Issue 1, October 2014, Pages: 112–130, David R. Gastfriend

    Version of Record online : 18 SEP 2014, DOI: 10.1111/nyas.12538